Ashland

http://www.pharmtech.com/pt_w/manufacturing


	Continuous processing is one of the most important innovations in modern pharmaceutical manufacturing. Tremendous efforts have been made in process, formulation, and analytical technologies to support this trend. Most excipients currently available, however, are designed for batch processes; the industry has unmet needs for excipients that can truly enable continuous manufacturing. Most pharmaceutical scientists are not aware of their important roles in rational design and selection of excipients for continuous manufacturing. This presentation will:

		Showcase the strategies from leading pharmaceutical excipient suppliers on conceptualizing, designing, engineering, and testing excipients that specifically serve the needs of continuous manufacturing

		Display case studies that exemplify the importance of collaboration efforts between pharmaceutical scientists and excipients suppliers

		Review the fundamentals and principles of continuous processing

		Understand the rational excipient choice in continuous processing

		Learn about improved efficiency with high-solids coatings

Andrew Birkmire, Process Development Manager, GEA Process Engineering

	Dr. Tom Dürig, Senior R&D Director, Ashland

	Kapish Karan, Team Leader, Pharmaceutical and Nutraceutical R&D and Global Film-Coating Platform Leader, Ashland

Thursday, Sept. 26, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

	On demand available after airing until Sept. 26, 2020

Webcasts

Learn how to evaluate excipients for continuous manufacturing in a rational fashion. This webcast will demonstrate the importance of collaboration between pharmaceutical scientists and excipient suppliers as the industry continues its quest to optimize manufacturing processes for cost and scale efficiencies. 
Live: Thursday, Sept. 26, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Sept. 26, 2020 
Register free


Ashland

Articles